Melodie Victoria Lacson
Family · San Marcos, CANPI 1588370332
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.4% of the total across 202 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 202 payments — averaging $20.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$822
- AbbVie$676
- Novartis$493
- UCB, Inc.$397
- Johnson & Johnson$326
- GSK$307
- plus $1K from 14 others
What the payments were for
- Food & beverage$4,08696%
- Education$1544%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 44 | $822 |
| AbbVie | 40 | $676 |
| Novartis | 17 | $493 |
| UCB, Inc. | 19 | $397 |
| Johnson & Johnson | 18 | $326 |
| GSK | 14 | $307 |
| Lilly USA, LLC | 12 | $224 |
| AstraZeneca | 7 | $182 |
| E.r. Squibb & Sons, L.L.C. | 5 | $144 |
| Boehringer Ingelheim | 5 | $132 |
| Actelion Pharmaceuticals US, Inc. | 2 | $88 |
| Aurinia Pharma U.S., Inc. | 3 | $83 |
| Pfizer | 3 | $79 |
| Scilex Pharmaceuticals Inc. | 3 | $68 |
| Kiniksa Pharmaceuticals International, PLC | 3 | $58 |
| Kyowa Kirin, Inc. | 2 | $44 |
| ANI Pharmaceuticals, Inc. | 1 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $33 |
| Mallinckrodt Hospital Products Inc. | 1 | $31 |
| Genentech USA, Inc. | 1 | $22 |
How this compares
$4,240 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 185 | $6,779 |
| MethotrexateMethotrexate Sodium | 65 | $1,314 |
| Leflunomide | 35 | $1,247 |
| Diclofenac Sodium | 23 | $279 |
| Prednisone | 59 | $214 |
| Folic Acid | 15 | $181 |
| Allopurinol | 31 | $105 |
| Meloxicam | 30 | $77 |
Paid to pharmacies, not to this prescriber.
Other family in San Marcos
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.